Quick answers
- What is Chromic chloride used for?
- The FDA-approved label (Chromium, Hospira, Inc., June 24, 2026) says: “Chromium 4 mcg/mL (Chromic Chloride Injection, USP) is indicated for use as a supplement to intravenous solutions given for TPN. Administration helps to maintain chromium serum levels and to prevent depletion of endogenous stores and subsequent deficiency symptoms.” This page is not medical advice. Talk to your doctor or pharmacist before you start, stop or change any medicine.
- Does Chromic chloride have a boxed warning?
- No. None of the 3 FDA labels we found for this medicine has a boxed warning.
- Is there a shortage of Chromic chloride?
- No current shortage is listed by the FDA for the products of this medicine (FDA data from October 30, 2026).
- Has Chromic chloride been recalled?
- FDA enforcement reports list 1 recall of products of this medicine; the newest started November 1, 2016 (Class II). A recall usually concerns specific lots, not every product.
- Who makes Chromic chloride?
- 2 companies list prescription products of Chromic chloride in the FDA NDC Directory, including Hospira, Inc. and Archis Pharma LLC.
What Chromic chloride is used for
Quoted from the “Indications and Usage” section of the FDA-approved label.
Chromium 4 mcg/mL (Chromic Chloride Injection, USP) is indicated for use as a supplement to intravenous solutions given for TPN. Administration helps to maintain chromium serum levels and to prevent depletion of endogenous stores and subsequent deficiency symptoms.
— FDA label: Chromium, Hospira, Inc., effective June 24, 2026. Read the full label on DailyMed →
The FDA has 3 labels for products of this medicine (different makers and forms); uses can differ between them. Check the label that comes with your own medicine.
This page is not medical advice. Talk to your doctor or pharmacist before you start, stop or change any medicine.
Boxed warning
A boxed warning (“black box”) is the FDA’s strongest warning on a drug label, for serious or life-threatening risks.
The label quoted above has no boxed warning.
0 of 3 FDA labels for this medicine have a boxed warning.
Forms and how it is given
| Dosage forms | Injection, solution |
|---|---|
| Route | Intravenous |
| Prescription products | 2 in the FDA NDC Directory |
| Brand names | Chromium |
Companies that list this medicine
Labelers in the FDA NDC Directory: the company named on the package (maker or distributor), with the number of prescription products.
- Hospira, Inc.2 products
- Archis Pharma LLC1 product
FDA approval history
- NDA: New Drug Application: how a new (usually brand-name) medicine is approved.
- ANDA: Abbreviated New Drug Application: how a generic version is approved.
| Application | Sponsor | Approved | Later changes approved |
|---|---|---|---|
| NDA018961 CHROMIC CHLORIDE IN PLASTIC CONTAINER | Hospira | June 26, 1986 | 11, latest June 12, 2014 2014: Manufacturing (CMC) · 2002: Labeling · 2001: Manufacturing (CMC) |
Generic approvals (1)
- ANDA218538Somerset Theraps LLC · November 18, 2024
Shortage status
The FDA drug shortage list does not show these products.
Recalls
From FDA enforcement reports, matched by the product’s NDC code. A recall usually covers specific lots only: check the lot number on your package and ask your pharmacist. Do not stop a medicine on your own.
-
November 1, 2016 · Class II · Terminated · D-0153-2017
Lack of Assurance of Sterility: Complaints of broken tips on the ampules.
Fentanyl Citrate Injection, USP, 100 mcg Fentanyl/ 2mL, Single Dose, 50 mcg/mL, Rx only, Hospira, Inc., Lake Forest IL 60045, NDC 0409-4093-32 — Hospira Inc.
What do the recall classes mean?
Class I: The most serious type: there is a reasonable chance that using the product will cause serious health problems or death.
Class II: Using the product may cause temporary or medically reversible health problems, or the chance of serious problems is remote.
Class III: Using the product is not likely to cause health problems (for example a labeling or packaging issue).
Official identifiers
| RxCUI (RxNorm) | 204401 |
|---|---|
| SPL set ID of the quoted label | da207ca8-7836-4c66-92fe-36cc89baf773 |
| FDA labels (SPL) | 3 |
| FDA applications | NDA018961, 1 ANDA |
| Active ingredients (FDA) | CHROMIC CHLORIDE |
Sources
- FDA-approved label on DailyMed (National Library of Medicine) — Chromium, Hospira, Inc., effective June 24, 2026; via openFDA, FDA data exported October 30, 2026, retrieved October 31, 2026
- NDC Directory (openFDA) — U.S. Food and Drug Administration (FDA), FDA data exported October 30, 2026, retrieved October 31, 2026
- Drugs@FDA (openFDA) — U.S. Food and Drug Administration (FDA), FDA data exported October 30, 2026, retrieved October 31, 2026
- Drug recall enforcement reports (openFDA) — U.S. Food and Drug Administration (FDA), FDA data exported October 27, 2026, retrieved October 31, 2026
- Drug shortages (openFDA) — U.S. Food and Drug Administration (FDA), FDA data exported October 30, 2026, retrieved October 31, 2026
openFDA data is provided by the FDA as is; it may be incomplete. Always rely on the label that comes with your medicine. FDA Enforcement Report search →